1997
DOI: 10.1016/s0169-328x(96)00189-1
|View full text |Cite
|
Sign up to set email alerts
|

μ-Opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1999
1999
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 42 publications
0
6
0
Order By: Relevance
“…The unexpected positive coupling of G i/o -coupled receptors, including MOR, can occur through G βγ -activation of type-II adenylyl cyclase, provided Gα s is present [22,23,24]. Because oocytes express type-II adenylyl cyclase endogenously [25], we hypothesized that the unexpected activation of HCN2 by MOR occurred in those oocytes that expressed a low level of the Gα s subunit. To investigate whether Gα s subunits provide the missing factor for activating type-II adenylyl cyclase via MOR in all oocytes, we coexpressed a constitutively active Gα s mutant (Gα s Q227L) in all following experiments, similar to previous experiments performed in mammalian cells [24].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The unexpected positive coupling of G i/o -coupled receptors, including MOR, can occur through G βγ -activation of type-II adenylyl cyclase, provided Gα s is present [22,23,24]. Because oocytes express type-II adenylyl cyclase endogenously [25], we hypothesized that the unexpected activation of HCN2 by MOR occurred in those oocytes that expressed a low level of the Gα s subunit. To investigate whether Gα s subunits provide the missing factor for activating type-II adenylyl cyclase via MOR in all oocytes, we coexpressed a constitutively active Gα s mutant (Gα s Q227L) in all following experiments, similar to previous experiments performed in mammalian cells [24].…”
Section: Resultsmentioning
confidence: 99%
“…In summary, G i/o -coupled receptors are able to modulate I h in opposing manner, depending on the isotype of adenylyl cyclase co-existing within the same neuron or heterologous expression system. If βγ-stimulated adenylyl cyclases co-exist (as endogenously expressed in Xenopus oocytes [25]), the receptor will cause an increase of the intracellular cAMP concentration, in turn enhancing I h .…”
Section: Discussionmentioning
confidence: 99%
“…Oligonucleotides designed against the C1 domain of the Xenopus AC2 fragment described by Wotta et al (1997), were used to amplify by PCR a DNA fragment from a cDNA Xenopus oocyte library (Clontech, Palo Alto, CA, USA). The forward primer was 5 0 -CTCATC-GATGGGGACTCTTATTATTGTGT-3 0 which corresponds to the 5 0 -conserved LIDGDCYYCV sequence.…”
Section: Xenopus Oocyte Ac Cloningmentioning
confidence: 99%
“…To identify this AC, at the molecular level, we synthesized specific oligonucleotides based in a short Xenopus AC2 cDNA sequence (Wotta et al, 1997) and a Xenopus EST (BJ068695). Through this approach, we amplified by PCR a gene encoding an AC, which showed higher identity to the subgroup of Gbg-stimulated mammalian ACs (44% to AC7, 38% to AC2, and 35% to AC4) than to the other isotypes (25% to AC1, 23% to AC6, 21% to AC5 and AC3, 19% to AC8, and 15% to AC9).…”
Section: Xenopus Oocyte Ac Activity Is Characteristic Of Ac2 Isoformmentioning
confidence: 99%
“…In epithelial cells, cAMP also activated CFTR (Gadsby and Nairn, 1999), but no data are available concerning an elevation of cAMP by ␤ 2 -AR stimulation in those cells. However, in Xenopus laevis oocytes, the ␤ 2 -AR stimulation produced an activation of adenylyl cyclase that increased the concentration of intracellular cAMP, leading to an activation of CFTR channel gating (Wotta et al, 1997). Our group has demonstrated in a recombinant system, a human lung epithelialderived cell line (A549), that CFTR is regulated by ␤ 3 -AR stimulation produced either by isoproterenol (a nonselective ␤-AR agonist) in the presence of nadolol (a ␤ 1 , ␤ 2 -AR antagonist), SR 58611A (a preferential ␤ 3 -AR agonist), or CGP-12177 (a partial ␤ 3 -AR agonist) (Leblais et al, 1999).…”
mentioning
confidence: 99%